AXL Targeting Restores PD-1 Blockade Sensitivity of STK11/LKB1 Mutant NSCLC through Expansion of TCF1+ CD8 T Cells

0
42
Investigators demonstrated that AXL was a critical targetable driver of immune suppression in STK11/LKB1 mutant NSCLC.
[Cell Reports Medicine]
Full ArticleGraphical Abstract